Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
12.67
Sep 23 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
795.26M
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Sep 18, 2026
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
7.64%
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-5.20%
SMA50
-5.20%
SMA200
-5.20%
Trades
Shs Outstand
62.77M
Shs Float
-
52W High
15.50 -18.26%
52W Low
12.50 1.36%
Volatility
- -
ATR (14)
1.54
RSI (14)
-
Beta
-
Rel Volume
0.00
Avg Volume
1.81M
Volume
0
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
Perf YTD
-15.53%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
12.67
Price
12.67
Change %
0.00%
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Pharm.D.Dr. Quehuong Dong M.B.A.
Chief Technology OfficerMr. Gary S. Koe Ph.D.
Ph.D.Dr. Kim-Hien Dao D.O.
Chief Financial OfficerMr. Christopher W. Clark C.F.A.
Chief Scientific OfficerDr. Graham Parry Ph.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GORDON CARL LDirectorSep 21 '26Buy15.001,333,33319,999,9955,126,891Sep 23 05:35 PM
ORBIMED ADVISORS LLCDirectorSep 21 '26Buy15.001,333,33319,999,9955,126,891Sep 23 05:29 PM